Fragment-based Drug Design
This blog by Dan Earlanson is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments.
Derek Lowe’s commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine.
Academic-Industry Partnerships: Harder, better, faster
In Nature Chemistry, Merck scientists Danielle Schultz and Louis-Charles Campeau discuss how to bridge the gap between fundamental academic research and the applied industrial research by engaging in well-defined collaborative projects and fostering better communication between scientists involved in them.
Research Training INSIGHTS
Advancing Australia’s Knowledge Economy
In this report from AMSI and CSIRO Data61’s student‑employer matching platform, Ribit.net, they have investigated which sectors within the Australian workforce employ PhD holders, and what the career ambitions of current PhD students are.
